HHS partners to develop COVID-19 immunotherapies; plasma donation encouraged
Collaborating with non-governmental organizations, the Department of Health and Human Services is working to develop convalescent plasma and hyperimmune globulin immunotherapies for COVID-19 patients. Both products use blood plasma from recovered patients, which contain SARS-CoV-2 antibodies that could stimulate the immune system for COVID-19 patients. Patients who have recovered from COVID-19 can learn more about donating plasma here.
Related News Articles
Headline
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…
Headline
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…
Headline
The Department of Health and Human Services Sept. 18 announced it will take new actions to help improve care for individuals with long COVID. They include a…
Headline
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…
Headline
The Centers for Disease Control and Prevention is predicting a similar combined number of peak hospitalizations from COVID-19, the flu and respiratory…
Headline
The Occupational Safety and Health Administration today announced a 60-day extension of the comment period on its proposed rule to remove the remaining…